Details of the Drug

General Information of Drug (ID: DM1AT65)

Drug Name

NY-ESO-1/LAGE-1-specific T-cells

Indication

Disease Entry	ICD 11	Status	REF
Sarcoma	2A60-2C35	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01567891) Autologous T Cells Expressing Enhanced TCRs Specific for NYESO-1/LAGE in Patients With Ovarian Cancer. U.S. National Institutes of Health.